🇺🇸 FDA

Drug profile · INN

sodium phosphate, dibasic, heptahydrate

SODIUM PHOSPHATES IN PLASTIC CONTAINER

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

sodium phosphate, dibasic, heptahydrate (SODIUM PHOSPHATES IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN sodium phosphate, dibasic, heptahydrate
Brand SODIUM PHOSPHATES IN PLASTIC CONTAINER
Route INTRAVENOUS
Formulation SOLUTION
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is sodium phosphate, dibasic, heptahydrate?

sodium phosphate, dibasic, heptahydrate (SODIUM PHOSPHATES IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for sodium phosphate, dibasic, heptahydrate?

SODIUM PHOSPHATES IN PLASTIC CONTAINER is a marketed brand name for sodium phosphate, dibasic, heptahydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium phosphate, dibasic, heptahydrate?

sodium phosphate, dibasic, heptahydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.